Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016

Yngvar Nilssen; Odd Terje Brustugun; Morten Tandberg Eriksen; Erik Skaaheim Haug; Bjørn Naume; Bjørn Møller

doi:10.1186/s12885-020-06979-y

BMC Cancer

Table 2 Univariable and multivariable analysis for not being included in cancer patient pathways among colorectal, lung, breast and prostate cancer patients diagnosed in 2015–2016 in Norway

From: Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016

	Colorectal		Lung		Breast		Prostate
	Univariate	Multivariate	Univariate	Multivariate	Univariate	Multivariate	Univariate	Multivariate
	OR [95%CI]*	OR [95%CI]*	OR [95%CI]*	OR [95%CI]*	OR [95%CI]*	OR [95%CI]*	OR [95%CI]*	OR [95%CI]*
Year of diagnosis
2015	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]
2016	0.61 [0.55,0.69]	0.60 [0.54,0.68]	0.58 [0.51,0.66]	0.55 [0.47,0.63]	0.33 [0.27,0.41]	0.31 [0.25,0.39]	0.56 [0.51,0.61]	0.51 [0.47,0.56]
p-value	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
Age group
18–49	2.34 [1.81,3.04]	2.23 [1.70,2.91]	1.06 [0.63,1.78]	1.18 [0.69,2.01]	0.75 [0.55,1.02]	0.77 [0.56,1.06]	0.82 [0.53,1.25]	0.75 [0.48,1.16]
50–59	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]
60–69	0.92 [0.74,1.14]	0.89 [0.72,1.11]	1.02 [0.78,1.33]	1.00 [0.76,1.32]	0.91 [0.70,1.18]	0.88 [0.67,1.15]	0.89 [0.77,1.03]	0.94 [0.81,1.09]
70–79	1.00 [0.82,1.23]	0.93 [0.75,1.16]	1.19 [0.92,1.54]	1.11 [0.85,1.45]	1.00 [0.74,1.35]	0.79 [0.57,1.10]	1.37 [1.19,1.59]	1.58 [1.35,1.85]
80–89	1.32 [1.07,1.63]	1.15 [0.92,1.45]	2.63 [2.01,3.44]	2.21 [1.67,2.94]	1.13 [0.80,1.61]	0.74 [0.49,1.10]	4.46 [3.75,5.31]	5.59 [4.60,6.78]
90+	3.31 [2.48,4.41]	2.50 [1.83,3.40]	5.39 [3.40,8.55]	4.68 [2.87,7.63]	1.45 [0.84,2.52]	0.92 [0.50,1.68]	14.0 [8.8,22.3]	17.3[10.7,28.0]
p-value	< 0.001	< 0.001	< 0.001	< 0.001	0.138	0.509	< 0.001	< 0.001
Sex
Female	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]
Male	0.87 [0.78,0.97]	0.93 [0.83,1.05]	0.91 [0.80,1.04]	0.86 [0.75,0.99]			1.00 [1.00,1.00]	1.00 [1.00,1.00]
p-value	0.014	0.240	0.152	0.040
Stage^a
A	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]
B	0.58 [0.50,0.67]	0.57 [0.49,0.66]	1.34 [1.04,1.74]	1.41 [1.09,1.83]	1.01 [0.72,1.40]	1.02 [0.73,1.43]	0.52 [0.46,0.57]	0.44 [0.39,0.49]
C	1.20 [1.03,1.41]	1.19 [1.01,1.40]	3.25 [2.59,4.08]	3.44 [2.72,4.35]	5.21 [3.77,7.20]	5.94 [4.20,8.40]	1.24 [1.04,1.47]	0.74 [0.61,0.89]
D	1.41 [1.14,1.73]	1.22 [0.98,1.52]	4.28 [3.31,5.54]	4.08 [3.12,5.32]	3.33 [2.45,4.51]	3.36 [2.41,4.68]	0.86 [0.76,0.96]	0.69 [0.61,0.78]
p-value	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
Marital status
Single	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]
Married	0.71 [0.64,0.79]	0.81 [0.72,0.92]	0.82 [0.72,0.94]	0.93 [0.81,1.08]	1.02 [0.84,1.23]	1.03 [0.83,1.28]	0.89 [0.81,0.97]	0.89 [0.80,0.98]
p-value	< 0.001	< 0.001	0.003	0.351	0.870	0.776	0.010	0.022
Education
Low	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]
Intermediate	0.84 [0.74,0.95]	0.95 [0.83,1.09]	0.85 [0.74,0.98]	0.96 [0.83,1.12]	0.84 [0.66,1.06]	0.92 [0.72,1.18]	0.79 [0.71,0.88]	0.92 [0.82,1.04]
High	0.85 [0.73,0.99]	0.98 [0.82,1.17]	0.71 [0.57,0.89]	0.88 [0.68,1.13]	0.75 [0.58,0.96]	0.97 [0.72,1.31]	0.81 [0.72,0.92]	1.03 [0.89,1.18]
p-value	0.015	0.770	0.004	0.592	0.079	0.796	< 0.001	0.120
Income
Low	1.29 [1.07,1.55]	1.24 [1.00,1.54]	1.97 [1.55,2.51]	1.52 [1.16,1.99]	1.72 [1.27,2.33]	1.42 [0.99,2.03]	1.72 [1.47,2.02]	1.05 [0.87,1.27]
Intermediate	1.15 [1.00,1.32]	1.13 [0.97,1.33]	1.47 [1.21,1.81]	1.16 [0.93,1.45]	1.39 [1.13,1.72]	1.21 [0.94,1.54]	1.29 [1.18,1.42]	0.94 [0.84,1.05]
High	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]
p-value	0.025	0.146	< 0.001	0.004	< 0.001	0.135	< 0.001	0.310
Region^b
South-East	1.10 [1.04,1.16]	1.11 [1.05,1.17]	1.07 [1.01,1.14]	1.08 [1.01,1.15]	0.85 [0.78,0.93]	0.85 [0.78,0.93]	0.95 [0.91,0.98]	0.96 [0.92,1.00]
West	0.93 [0.83,1.04]	0.93 [0.83,1.04]	0.99 [0.88,1.13]	1.01 [0.88,1.15]	1.12 [0.92,1.36]	1.09 [0.89,1.33]	1.41 [1.30,1.53]	1.39 [1.27,1.51]
Mid	1.10 [0.97,1.25]	1.09 [0.95,1.25]	1.21 [1.02,1.42]	1.22 [1.02,1.45]	2.67 [2.22,3.21]	2.82 [2.32,3.43]	0.76 [0.68,0.85]	0.75 [0.67,0.84]
North	0.62 [0.51,0.75]	0.59 [0.49,0.72]	0.55 [0.44,0.70]	0.52 [0.41,0.66]	0.48 [0.31,0.75]	0.48 [0.31,0.75]	1.02 [0.89,1.17]	1.04 [0.89,1.20]
p-value	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
Comorbidity
No admissions	1.01 [0.75,1.36]	0.97 [0.71,1.32]	0.53 [0.26,1.06]	0.48 [0.23,0.97]	0.74 [0.58,0.96]	0.90 [0.69,1.17]	1.76 [1.55,2.00]	2.00 [1.75,2.29]
0	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]	1.00 [1.00,1.00]
1–2	1.21 [1.06,1.39]	1.18 [1.02,1.36]	1.23 [1.07,1.41]	1.28 [1.10,1.49]	1.09 [0.79,1.51]	1.07 [0.75,1.51]	1.65 [1.47,1.85]	1.38 [1.22,1.56]
3+	1.83 [1.42,2.36]	1.67 [1.28,2.18]	1.95 [1.55,2.45]	1.90 [1.48,2.44]	1.94 [1.02,3.68]	1.09 [0.54,2.19]	3.24 [2.52,4.17]	2.31 [1.75,3.06]
p-value	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001

^aColorectal, lung and prostate: Localised (A), Regional (B), Metastasis (C), Unknown (D). Breast: Stage I-II (A), Stage III (B), Stage IV (C), Unknown (D)
^bCompared with Norway (mean)
^*Odds Ratio [95% c onfidence interval]

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com